C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis

Atherosclerosis

Volumn 136, Issue 1, 1998, Pages 17-24

  Schreyer, Sandra A ^a   Wilson, Deborah L ^a   Leboeuf, Renée C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Diabetes; Dietary fat; Mice

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; EXPERIMENTAL MODEL; FAT INTAKE; FEMALE; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC PARAMETERS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIET, ATHEROGENIC; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE TOLERANCE TEST; LIPIDS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PHENOTYPE;

EID: 0031852458     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00165-2     Document Type: Article

References (23)

1. Garcia M.J., McNamara G.W., Hutchins G.M. Morbidity and mortality in diabetics in the Framingham population: Sixteen year follow up study. Diabetes. 23:1974;105-111.
2. Koskinen P., Manttari M., Manninen V., Huttunen J.K., Heinonen O.P., Frick M.H. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care. 15:1992;820-825.
3. Sprafka J.M., Xue S., Bushhouse S.A., French L.R., Martinez A.M., Goetz F.C. Cardiovascular disease risk factors and glucose tolerance. The Wadena City Health Study. Ann Epidemiol. 2:1992;647-656.
4. Paigen B., Ishida B.Y., Verstuyft J., Winters R.B., Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 10:1990;316-323.
5. Paigen B., Mitchell D., Reue K., Morrow A., Lusis A.J., LeBoeuf R.C. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA. 84:1987;3763-3767.
6. Liao F., Andalibi A., deBeer F.C., Fogelman A.M., Lusis A.J. Genetic control of inflammatory gene induction and NF-kB transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 91:1993;2572-2579.
7. Mehrabian M., Demer L.L., Lusis A.J. Differential accumulation of intimal monocyte-macrophage relative to lipoproteins and lipofuscin corresponds to hemodynamic forces on cardiac valves in mice. Arterioscler Thromb. 11:1991;947-957.
8. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., Feinglos M.N. Diet induced type II diabetes in C57BL/6J mice. Diabetes. 37:1988;1163-1167.
9. Surwit R.S., Seldin M.F., Kuhn C.M., Cochrane C., Feinglos M.N. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes. 40:1991;82-87.
10. Surwit R.S., Feinglos M.N., Rodin J., Sutherland A., Petro A.E., Opara E.C., Kuhn C.M., Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6 and A/J mice. Metabolism. 44:1995;645-651.
11. Lusis A.J., LeBoeuf R.C. Genetic control of mammalian lipoproteins: Mouse model. Methods Enzymol. 128:1986;877-894.
12. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
13. LeBoeuf R.C., Caldwell M., Kirk E. Regulation by nutritional status of lipids and apolipoproteins A-I, A-II and A-IV in inbred mice. J Lipid Res. 35:1995;121-133.
14. Kirk E.A., Moe G.L., Caldwell M.T., Lernmark J.A., Wilson D.L., LeBoeuf R.C. Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice: Searching for level and variability genes. J Lipid Res. 36:1995;1522-1532.
15. Kaku K., Fiedorek F.T. Jr., Province M., Permutt M.A. Genetic analysis of glucose tolerance in inbred mouse strains. Diabetes. 37:1988;707-713.
16. Bonora E., Moghetti P., Zancanaro C., Cigolini M., Querena M., Cacciatori V., Crognati A., Muggeo M. Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 68:1989;374-378.
17. Kunjathoor V.V., Wilson D.L., LeBoeuf R.C. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest. 97:1996;1767-1773.
18. Paigen B., Morrow A., Brandon C., Mitchell D., Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 87:1985;65-73.
19. Hayek T., Ito Y., Azrolan N., Verdery R.B., Aalto-Setala K., Walsh A., Breslow N. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-1 transgenic and control mice. J Clin Invest. 91:1993;1665-1671.
20. Srivastava R.A. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism. Biochem Mol Biol Int. 34:1994;393-402.
21. Jiao S., Cole T.G., Kitchens R.T., Pfleger B., Schonfeld G. Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors. J Lipid Res. 31:1990;467-477.
22. Qiao J.H., Xie P.Z., Fishbein M.C., Kreuzer J., Drake T.A., Demer L.L., Lusis A.J. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb. 14:1994;1480-1497.
23. Nishina P.M., Naggert J.K., Verstuyft J., Paigen B. Atherosclerosis in genetically obese mice: The mutants obese, diabetes, fat, tubby and lethal yellow. Metabolism. 43:1994;554-558.